Clinical Trials
Printable Version   Email to a friend

Heart Failure Patient Recovers After Cellmedicine Adult Stem Cell Therapy

SAN DIEGO--(BUSINESS WIRE)--Oct 5, 2007 - In December 2006, The Institute of Cellular Medicine (www.cellmedicine.com) treated a no-option cardiac patient with adult stem cells. Since being treated, the patient has undergone profound recovery, improving his ejection fraction rate from approximately 30% (clinical heart failure) to over 50% which is well within the boundaries of a normal, healthy adult. The Institute of Cellular Medicine recently interviewed the patient to get his perspective on the treatment, his recovery, and outlook on the future.

"My options were A) Wait and see what happens with time B) Wait till I needed a heart transplant or C) Wait till I die, so I started looking around and I found out about ICM on the Internet." On his recovery, "After the fourth treatment I felt my whole body had changed. I no longer felt fatigued, the shortness of breath had gone away and my energy levels went through the roof." As for the future, the patient concluded, "ICM gave me the opportunity to get my life back."

The video is freely accessible at http://www.youtube.com/watch?v=PcFQeRNuPDo

All stem cell therapies and know-how used by The Institute of Cellular Medicine are under license from the US public company Medistem Laboratories (MDSM.OB).

Contact

The Institute of Cellular Medicine
Dr. Gang Chen, 1-800-980-STEM

Latest Clinical Trial Results...

Clinical Trial Results Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Dec

More News Resources


MedNotes
Advertisement